And It's About Time There Was Some Support For Cushing's!
Prolactin is a hormone that induces lactation or milk formation. The size of the prolactinoma correlates with the excess prolactin level; the larger the tumor, the higher the level of prolactin that is secreted. Smaller tumors, called microprolactinomas are more common in women, and larger tumors, called macroprolactinomas, are more common in men. Many of the smaller tumors do not appear to progress to larger tumors.
Many women first experience symptoms while on oral contraceptives or have cessation of menses when oral contraceptives are discontinued.
Prolactinomas may grow during pregnancy and may be diagnosed in the postpartum period. Sexual dysfunction occurs in many men. Prolactinomas occur most commonly in those under 40 years old. The incidence is 3 out of 10,000 men and 1 out of 1,000 women.
The symptoms of infertility, irregular menses, decreased sexual interest, and milk flow not related to childbirth or nursing can be improved with treatment. Men should also be treated when decreased sexual drive, infertility, or impotence are present.
Bromocriptine (a dopamine agonist medication) is a medication used to return prolactin levels to normal in both men and women. Larger tumors or those resistant to bromocriptine may respond to surgical resection, radiation therapy, or a combination of treatments.
Long-term studies are not available for information on prognosis (probable outcome).
Tumor regrowth is the main complication.
Call for an appointment with your health care provider if symptoms of a prolactinoma develop. If you have had a prolactinoma in the past, call for an appointment with your health care provider if you experience recurrence of the symptoms.
There is no known prevention.
The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. (See disclaimer).